Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and
pathologic diagnosis of DLB incorporating new information about the core clinical features and …
pathologic diagnosis of DLB incorporating new information about the core clinical features and …
[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a …
…, KL Kotloff, A Krishnan, R Libster, O Lopez… - The Lancet, 2017 - thelancet.com
Background We have previously estimated that respiratory syncytial virus (RSV) was associated
with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in …
with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in …
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke …
…, C Iadecola, LJ Launer, S Laurent, OL Lopez… - stroke, 2011 - Am Heart Assoc
Background and Purpose— This scientific statement provides an overview of the evidence
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study
CG Lyketsos, O Lopez, B Jones, AL Fitzpatrick… - Jama, 2002 - jamanetwork.com
ContextMild cognitive impairment (MCI) may be a precursor to dementia, at least in some
cases. Dementia and MCI are associated with neuropsychiatric symptoms in clinical samples. …
cases. Dementia and MCI are associated with neuropsychiatric symptoms in clinical samples. …
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
…, MA Ikram, AL DeStefano, AL Fitzpatrick, O Lopez… - Nature …, 2011 - nature.com
We sought to identify new susceptibility loci for Alzheimer's disease through a staged
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory
…, A MacMillan, T Shelley, OL Lopez… - The Journal of …, 2000 - Am Neuropsych Assoc
The Neuropsychiatric Inventory (NPI) is a validated clinical instrument for evaluating
psychopathology in dementia. The authors developed a brief questionnaire form of the NPI (NPI-Q), …
psychopathology in dementia. The authors developed a brief questionnaire form of the NPI (NPI-Q), …
Genome-wide analysis of genetic loci associated with Alzheimer disease
… ), and Psychology (Dr Becker), and Alzheimer's Disease Research Center (Drs Becker and
Lopez), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Inserm U708 …
Lopez), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Inserm U708 …
… update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of …
RC Petersen, O Lopez, MJ Armstrong, TSD Getchius… - Neurology, 2018 - AAN Enterprises
… Lopez: study concept and design, analysis or interpretation of data, drafting/revising the
manuscript, critical revision of the manuscript for important intellectual content. Dr. Armstrong: …
manuscript, critical revision of the manuscript for important intellectual content. Dr. Armstrong: …
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …